Portage Biotech Ownership | Who Owns Portage Biotech?

Portage Biotech shareholders are primarily institutional investors at 10.71%, followed by 36.40% insiders and 52.89% retail investors. The average institutional ownership in Portage Biotech's industry, Biotech Stocks , is 45.35%, which Portage Biotech falls below.

Portage Biotech’s largest shareholders are Ubs group (9.16K shares, 0.04%), Blackrock (8.2K shares, 0.04%), and Morgan stanley (2.5K shares, 0.01%). Together, they hold 0.10% of Portage Biotech’s total shares outstanding.

Yes, BlackRock owns 0.04% of Portage Biotech, totaling 8.2K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.74K$. In the last quarter, BlackRock decreased its holdings by -23.07K shares, a -73.77% change.

Credit agricole s a is Portage Biotech’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Portage Biotech shares, valued at 0$.

Fidelity Nasdaq Composite Index is the top mutual fund holder of Portage Biotech shares, with 0.04% of its total shares outstanding invested in 455 Portage Biotech shares.